Event Specialty: Bronchoscopy
Join us at STS 2020 in New Orleans!
The annual conference, and the world’s largest organization representing thoracic and cardiovascular surgeons, brings together over 4,200 attendees from around the globe. At this year’s show, you can learn about the Monarch™ Platform and robotic-assisted bronchoscopy at our activities listed below:
Saturday, January 25 from 7:00am – 10:30am Dr. John Lazar, Director of Thoracic Robotics at Washington Hospital Center, will proctor the Monarch™ Platform station during the Robotic hands-on sessions. This course gives cardiothoracic surgeons hands-on experience with technical skills, robotic instrumentations, and surgical techniques.
Saturday, January 25 from 12:30 – 1:30 pm Dr. John Lazar will also participate in a panel discussion/Q&A about robotic bronchoscopy. He will share his experience with the Monarch Platform.
Sunday, January 26 – Tuesday, January 28 Visit us at booth #133 to learn more about Monarch and robotic-assisted bronchoscopy. Get a demo firsthand and test drive our technology via simulated iPads.
Sunday, January 26 at 5:30 – 5:45 pm Join us as Dr. Paul Chomiak, thoracic surgeon and Director of Thoracic Surgical Oncology at the Sarasota Memorial Cancer Institute in Sarasota, Florida, shares his clinical experience with the Monarch™ Platform and the programmatic impact of the Monarch robotic-assisted bronchoscopy platform. Dr. Chomiak’s hospital was an early adopter of the Monarch™ Platform, launching their program in late 2018.Learn more about STS 2020
Complications from bronchoscopy are rare and most often minor, but if they occur, may include breathing difficulty, vocal cord spasm, hoarseness, slight fever, vomiting, dizziness, bronchial spasm, infection, low blood oxygen, bleeding from biopsied site, or an allergic reaction to medications. Only rarely do patients experience other more serious complications (for example, collapsed lung, respiratory failure, heart attack and/or cardiac arrhythmia).
Adverse effects from both Mini-PCNL and Ureteroscopy include pain, urinary tract infection, fever, hematuria (presence of blood in urine), exposure to low levels of radiation, retained or residual stones.
Adverse effects from ureteroscopy may include pain, perforation or injury to the ureter, resulting in extravasation of fluid and urine (urinoma), stricture of the ureter with risk of subsequent obstruction (hydronephrosis needing further repair), rare avulsion of the ureter, urinary blood clots, residual stones.
PCNL access may result in minor and major adverse effects. Minor effects include fever and nephrostomy leak. Major adverse effects may include injuries to pleura, liver, spleen, large vessels with related bleeding, gallbladder, duodenum, jejunum, colon with related cutaneous fistula, fever, pain, ileus, elevated counts.
Major adverse effects related to stone removal may include infection and urosepsis, intravascular fluid overload, extravasation of fluid, and post percutaneous nephrolithotomy bleeding.